register

News & Trends - Biotechnology

‘Innovation makes a real and measurable difference to people’s lives at their most vulnerable time’, says Noxopharm CEO: National Science Week

Health Industry Hub | August 16, 2023 |

Biotech News: Embarking on the next chapter of our interview series celebrating National Science Week, Dr Gisela Mautner, CEO and Managing Director of Australian biotech company Noxopharm delved into the intersection between innovation and the dynamic healthcare landscape.

At the heart of our conversation was the National Science Week theme, Innovation: Powering Future Industries. Dr Mautner’s articulation of her personal passion for STEM underscored the profound alignment between her dedication and the overarching theme.

“Innovation in the development of new technologies is absolutely central to bridging the gaps that we have in the current healthcare system, to be able to improve patients’ lives. This is why I’m so excited about STEM as it’s a relentless push of current boundaries. I feel it makes a real and measurable difference to people’s lives, and specifically to people’s lives at their most vulnerable time when they’re sick,” she stated.

Turning our attention to recent events, Dr Mautner shared the key highlights from the BIO International Convention. These highlights seamlessly converged with Noxopharm’s pioneering research pursuits, underscoring the organisation’s commitment to steering healthcare innovation toward new horizons.

Anticipating the future, Dr Mautner shared her perspectives on the forthcoming RNA Leaders Congress in Boston. Her observations regarding the conference’s alignment with the National Science Week theme emphasised the enduring impact of innovation as an enabler of progress within healthcare.

In reflecting upon the year so far, Dr Mautner shared a thoughtful evaluation of the accomplishments that resonate most profoundly. Her insights unveil strategic milestones that underscore Noxopharm’s pivotal contribution to shaping the trajectory of innovation in healthcare.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Manoj Saxena - Bayer

Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series

Health Industry Hub | July 18, 2024 |

In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]

More


News & Trends - Pharmaceuticals

Matt Zeller, Country President of Novartis ANZ

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]

More


Medical

First guidelines to stamp out rising scientific integrity issues in medical journals

First guidelines to stamp out rising scientific integrity issues in medical journals

Health Industry Hub | July 18, 2024 |

The number of retractions issued for scientific research articles in 2023 exceeded 10,000 – smashing annual records. To date, publishers […]

More


News & Trends - Pharmaceuticals

Gilead secures MSAC nod for CAR-T therapy

Gilead secures MSAC nod for CAR-T therapy

Health Industry Hub | July 18, 2024 |

Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]

More


This content is copyright protected. Please subscribe to gain access.